Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Altheos appoints new chief medical officer
Prior to joining Altheos, Wirostko worked with Pfizer as the senior medical director and the glaucoma medical team lead and was responsible for pipeline strategy in glaucoma, overseeing
Prior to joining Altheos, Wirostko worked with Pfizer as the senior medical director and the glaucoma medical team lead and was responsible for pipeline strategy in glaucoma, overseeing
Qualitest said that after a thorough evaluation of multiple quality management solutions, it has selected a phased implementation of TrackWise software for its ability to deliver a flexible,
The data demonstrated low rates of target lesion revascularisation (TLR) and side branch failure (3.6 and 1.2%, respectively), with no incidences of stent thromboses. Tryton Medical president and
Most recently, Bacopoulos worked as president and CEO of Aton Pharma. Prior to Aton Pharma, Bacopoulos served as the president and head of R&D at OSI Pharmaceuticals, where
Fondaparinux 1.5 and 2.5mg is indicated for the treatment of adults with acute symptomatic spontaneous superficial-vein thrombosis of the lower limbs without concomitant deep-vein thrombosis. Fondaparinux has received
The pre-filled syringes provide a simplified dosing option for the treatment of opioid-induced constipation (OIC) in palliative-care patients with advanced illness. Progenics said that the new pre-filled syringes
The RevitaLens Ocutec multi-purpose disinfecting solution delivers high-quality disinfection and comfort for the user, with the convenience of a single bottle, Abbott said. Abbott Medical Optics senior vice
Quidel claims that QuickVue RSV 10 detects RSV antigen directly from nasopharyngeal swab and nasopharyngeal aspirate/wash specimens from symptomatic patients under the age of six. Quidel president and
To initiate the production, Zydus Nycomed will manufacture Pantoprazole, Urapidil and Lornoxicam. Further, the company will produce eight additional APIs by 2011. Zydus Nycomed claims that the plant
The new polymer-based technology represents a practical way to integrate the use of NO into a variety of wound healing products, which could include granulated and powder dressings,